We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Janssen’s Leukemia Treatment Gets Soft ‘No’ from NICE
Janssen’s Leukemia Treatment Gets Soft ‘No’ from NICE
The UK’s National Institute for Health and Care Excellence refused to recommend Janssen’s chronic lymphocytic leukemia treatment Imbruvica for reimbursement on Wednesday, but left the door open to further discussion.